Sugi Predict

Sugi Predict / Compounds / SCHEMBL4793467

SCHEMBL4793467

SCHEMBL4793467

COC(=O)c1cc2cc[nH]c2nc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK8 P49336 1/20 0.46
▸ CHEK1 O14757 2/20 0.44
▸ MAPK14 Q16539 2/20 0.43
▸ GAA P10253 1/20 0.41
▸ KDR P35968 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ NR4A2 P43354 1/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ PDCD1 Q15116 1/20 0.39
▸ CD274 Q9NZQ7 1/20 0.39
▸ BRD4 O60885 2/20 0.38
▸ TTBK1 Q5TCY1 1/20 0.38
▸ TTBK2 Q6IQ55 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ FGFR1 P11362 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31403547 0.88 POLB (0.49) CDK8CHEK1MAPK14GAAKDR
SCHEMBL1779836 0.88 POLB (0.49) CDK8CHEK1MAPK14GAAKDR
SCHEMBL4792436 0.83 CDK8 (0.47) CDK8CHEK1GAAKDRKDM4E
SCHEMBL31497493 0.81 CHEK1 (0.50) CDK8CHEK1GAAKDRKDM4E
SCHEMBL28139173 0.81 CHEK1 (0.50) CDK8CHEK1GAAKDRKDM4E
SCHEMBL27960323 0.80 CDK8 (0.48) CDK8CHEK1KDRKDM4EALDH1A1
SCHEMBL5823323 0.76 NUDT1 (0.54) KDRKDM4EALDH1A1HPGDNPSR1
SCHEMBL24005535 0.75 BRD4 (0.43) CDK8MAPK14KDRBRD4POLB
SCHEMBL6421816 0.73 MAOB (0.52) CHEK1MAPK14KDM4EALDH1A1HPGD
SCHEMBL25346767 0.73 BRD4 (0.42) CDK8MAPK14KDRBRD4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7393851-B2 Azaindole derivatives as inhibitors of p38 kinase SCIOS, INC. (US) 2008-07-01 — — US disclosed
US-7393851-B2 Azaindole derivatives as inhibitors of p38 kinase SCIOS, INC. (US) 2008-07-01 — — US disclosed
US-7393851-B2 Azaindole derivatives as inhibitors of p38 kinase SCIOS, INC. (US) 2008-07-01 — — US disclosed
EP-1560582-A4 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE SCIOS INC (US) 2008-03-12 — — EP disclosed
WO-2006112828-A1 AZAINDOLE DERIVATIVES AS INHIBITORS OF P38 KINASE SCIOS, INC. (US) 2006-10-26 — — WO disclosed
US-20050288299-A1 Azaindole derivatives as inhibitors of p38 kinase SCIOS INC. 2005-12-29 — — US disclosed
EP-1560582-A2 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE SCIOS INC. (US) 2005-08-10 — — EP disclosed
US-20040176598-A1 Azaindole derivatives as inhibitors of p38 kinase SCIOS, INC. 2004-09-09 — — US disclosed
WO-2004032874-A2 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE SCIOS INC. (US) 2004-04-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288299-A1 Azaindole derivatives as inhibitors of p38 kinase MAPKAPK2, MAPK1, MAPK3 CDK8 155/4885CHEK1 389/4885MAPK14 21/4885
US-20040176598-A1 Azaindole derivatives as inhibitors of p38 kinase MAPKAPK2, MAPK1, MAPK4 CDK8 123/4885CHEK1 365/4885MAPK14 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.